Belladonna
drugOn this page
Also known as Atropa bella-donnaAtropa bella-donna wholeAtropa belladonnaAtropa belladonna whole floweringBelladonna total alkaloidsBelladonna wholeDeadly nightshadeDeadly nightshade whole
Summary
Belladonna (CHEMBL2108906) is a phase-3 clinical-stage unknown (ATC A03BA04); indicated across 2 conditions including breast neoplasm.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- ATC class: A03BA04
- Indications: 2 conditions
- Clinical trials: 6
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108906 |
| Name | Belladonna |
| Type | Unknown |
| Max phase | 3 |
| ATC | A03BA04 |
Also known as: Atropa bella-donna, Atropa bella-donna whole, Atropa belladonna, Atropa belladonna whole flowering, Belladonna, Belladonna total alkaloids, Belladonna whole, Deadly nightshade, Deadly nightshade whole, BELLADONNA
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| breast neoplasm | 3 | MONDO:0021100 | MONDO:0007254 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 6.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE4 | 6 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01150474 | PHASE4 | COMPLETED | Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery |
| NCT01271855 | PHASE4 | COMPLETED | Assessing Maternal Post-partum Pain With Suppositories |
| NCT02600715 | PHASE4 | COMPLETED | Reduction of Bladder Injection Pain With Belladonna Opiate Suppository |
| NCT02865395 | PHASE4 | TERMINATED | Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms |
| NCT03332056 | PHASE4 | COMPLETED | The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain |
| NCT03657407 | PHASE4 | COMPLETED | B&O for TLH Post-operative Pain and Nausea |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: breast neoplasm